מולטאק ישראל - עברית - Ministry of Health

מולטאק

sanofi israel ltd - dronedarone - טבליות מצופות פילם - dronedarone 400 mg - dronedarone - dronedarone - multaq is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (af). due to its safety profile, multaq should only be prescribed after alternative treatment options have been considered.multaq should not be given to patients with left ventricular systolic dysfunction or to patients with current or previous episodes of heart failure.

רמרון 30 מ"ג ישראל - עברית - Ministry of Health

רמרון 30 מ"ג

merck sharp & dohme israel ltd - mirtazapine 30 mg - tablets - mirtazapine - episode of major depression.

מירטאזאפין טבע  30 מג ישראל - עברית - Ministry of Health

מירטאזאפין טבע 30 מג

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

מירטאזאפין טבע  30 מג ישראל - עברית - Ministry of Health

מירטאזאפין טבע 30 מג

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

מירטאזאפין טבע   45 מג ישראל - עברית - Ministry of Health

מירטאזאפין טבע 45 מג

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

מירטאזאפין טבע   45 מג ישראל - עברית - Ministry of Health

מירטאזאפין טבע 45 מג

teva pharmaceutical industries ltd, israel - mirtazapine - טבליה - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

הייפרהפ בי אסדי ישראל - עברית - Ministry of Health

הייפרהפ בי אסדי

padagis israel agencies ltd, israel - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 220 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - for post-exposure prophylaxis such as: - acute exposure to blood containing hbsag, - perinatal exposure of infants born to hbsag-positive mothers, - sexual exposure to hbsag positive persons, - household exposure to persons with acute hbv infections.

הפאגם B ישראל - עברית - Ministry of Health

הפאגם b

tzamal bio-pharma ltd - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 312 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b recurrence following liver transplantation : hepagam b is indicated for the prevetion of hepatitis b recurrence following liver transplantation in hbsag-positive liver transplant patients. hepagam b should be administered intravenously for this indication.postexposure prophylaxis : hepagam b is indicated for the treatment of acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag-positive mothers sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving hbsag - positive materials such as blood plasma or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag. perinatal exposure of infants born to hbsag-positive

אקטיק 200 מקג ישראל - עברית - Ministry of Health

אקטיק 200 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 200 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

אקטיק 600 מקג ישראל - עברית - Ministry of Health

אקטיק 600 מקג

abic marketing ltd, israel - fentanyl as citrate - טבליות דחוסות על מקל - fentanyl as citrate 600 mcg/dose - fentanyl - fentanyl - actiq is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.